Sativa Wellness Group Extends its reach in COVID testing (Interview)

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL)Executive Chairman Geremy Thomas joins DirectorsTalk to discuss now being listed on the UK government website to offer 2 and 8 day quarantine tests. Geremy explains where they are with the clinic roll-out and how this will impact revenues.

Sativa Wellness Group goal is to build Europe’s leading CBD Wellness brands, to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain, they plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

With the growing demand for CBD products across the UK, their Goodbody suite of brands have already delivered strong organic growth and are well positioned to capture market share as the industry continues to grow. The brand portfolio is uniquely tailored to all key consumer demographics – from everyday and premium CBD products to pure hemp CBD-free offerings and sanitisation solutions.

You might also enjoy reading  Sativa Wellness Group Goodbody branded products to be offered at major discounts to competitor offerings
Find more news, interviews, share price & company profile here for:
Sativa Wellness Group inc

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Sativa Wellness Group Extends its reach in COVID testing (Interview)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions